key: cord-0860445-hea1f5v0
authors: Ozates, Serdar; Bostanci Ceran, Basak
title: Keeping an eye on the many symptoms of COVID-19
date: 2021-02-24
journal: Graefes Arch Clin Exp Ophthalmol
DOI: 10.1007/s00417-021-05125-z
sha: cbcaa863120d0961a0c6500f5a6e66dc994511e8
doc_id: 860445
cord_uid: hea1f5v0

nan

As of February 2021, coronavirus disease 2019 (COVID-19) has been proven to affect the world of ophthalmology in multiple dimensions such as examination, surgery, and treatment processes [1, 2] . Relatively within a short period, many articles provided information regarding preventive measures during examination and ophthalmological implications of COVID-19 [1] . Hyperemia, epiphora, photophobia, and foreign body sensations were the first reported ocular symptoms and findings associated with COVID-19 [3, 4] . Following reports showed the presence of novel severe acute respiratory syndrome coronavirus (SARS Cov-2) in the ocular surface and revealed the direct link of COVID-19 [5] . Conflicting results have been reported regarding association of ocular symptom severity and clinical approach of COVID-19.

First, ophthalmologic reports were limited to the ocular surface; however, uveitis, chorioretinitis, retinal vascular occlusion, retinal microangiopathy, optic neuritis, diplopia, and cranial nerve palsies were reported as the pandemic continued [6, 7] . While academic research has shown much evidence about COVID-19's ocular involvement, some critical questions still remain unanswered. Even in cases where COVID-19 appears to be the only possible etiological factor in patients, the available literature has not been able to describe these findings are directly related to COVID-19 or developed due to systemic complications of COVID-19. Promising results have been reported regarding the existence of SARS Cov-2 nucleic acid in the retina, vitreous, and aqueous humor in postmortem investigations; however, existence of complete SARS Cov-2 body and its infectivity in the ocular structures are still unknown [8, 9] .

In the light of the current literature, assuming COVID-19 as an etiologic factor for ocular disorders without significant proof may cause misdiagnosis and inappropriate treatment. In this case, it would be wise to consider COVID-19 as the underlying factor after ruling out all other possible etiological factors characterized by a similar clinical presentation.

Recently, new mutations of SARS Cov-2 have been announced, and new SARS CoV-2 variants are hypothesized to increase transmissibility [10] . Current literature does not provide information whether new mutations can chance the affinity of SARS Cov-2 to bind to the ocular structures, course of the ocular involvement, or the prevalence of ocular symptoms.

On the other hand, the effectiveness and protection of a global vaccination is still a controversial issue. The impact of vaccination on ocular symptoms and signs will be an attractive topic for future clinical studies. A large proportion of the population should be vaccinated to reliably assess the effect of vaccination on ocular symptoms.

Code availability Not applicable.

Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

Impacts of the SARS-CoV-2 pandemic on ophthalmic care in Germany

Ocular surface manifestations of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

Ocular manifestations of COVID-19: a systematic review and meta-analysis

Potential of ocular transmission of SARS-CoV-2: a review. Vision (Basel)

Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye

Ophthalmic and neuro-ophthalmic manifestations of coronavirus disease 2019 (COVID-19)

Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients

Presence of SARS-CoV-2 RNA in the cornea of viremic patients with COVID-19

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom